|Day Low/High||63.67 / 65.41|
|52 Wk Low/High||52.04 / 77.03|
Walgreens weak guidance is sending shares plummeting on Tuesday.
While today's action isn't attractive, we were ripe for a little profit-taking.
While the two companies seem very similar on the surface, CVS and Walgreens are different stocks for different types of investors.
I think sometimes the best way to parse the temperament is to go over the most obviously 'wrong' moves and address why they might not be wrong at all.
With all the unknowns surrounding Boeing it's way too early to take a position in the aircraft maker; the same is not true with CVS.
National security is job one. Cutting a nice deal with China that benefits both sides must come second.
This is hope, not fact -- don't pay more for the same old thing.
The market's reaction to the pharmacy giant's acquisition of Aetna is providing a rare opportunity to buy a quality company at a value price.
Why am I not more worried about a recession? Because Fed Chair Jay Powell has our back.
The market rally may be a rising tide, but investors should be wary of some of the stocks it has lifted up.
This is one where many shareholders can no longer take the pain and will sell at all costs.
CVS' spending spree has developed a deep debt issue for the company.
Pharmacy Benefit Managers (PBMs) are in for some problems if proposed regulation is given approval.
A period of repair will be needed before CVS looks attractive on the charts.
A shortened week still brings key economic numbers and earnings results.
File this under interesting. We all have come to accept that Amazon is attacking traditional retail, and that has led to a number of retailers flaming out while others look to defend, if not expand, their turf. For what it's worth, Walmart is doing ...
Apologies folks for the interruption... consider it a proof point for the demographic issue that is the aging domestic population as I had to deal with some issues regarding my dear ol' dad who will turn 87 in about six weeks. As we've seen by the r...
Expectations for Apple are all over the place.
The iPhone maker is a show-me stock ahead of its fiscal first-quarter results
It's likely that investors will be closely watching the U.S.-China trade talks to see if the skies brighten longer term.
Dow Theory presents tips for surviving a bear market, some top year-end stock bargains and a simple strategy for monthly income.
Buoying RMPIA during the first half of December were shares of Broadcom, Facebook and PayPal.
Underwater positions on stocks you feel lukewarm about are prime candidates for tax selling.
For the month of November RMPIA climbed 1.2% month over month.
Here are 4 stocks that can be bought into the stock cyclone that might occur if things don't go the bulls way in the Argentine.